Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index for Classification of Patients with Steatotic Liver Disease

被引:1
|
作者
Roy, Akash [1 ]
De, Arka [2 ]
Kulkarni, Anand V. [3 ]
Jajodia, Surabhi [4 ]
Goenka, Usha [4 ]
Tewari, Awanish [1 ]
Sonthalia, Nikhil [1 ]
Goenka, Mahesh K. [1 ]
机构
[1] Apollo Multispecial Hosp, Inst Gastrosci & Liver Transplantat, Kolkata, India
[2] Post Grad Inst Med Educ & Res, Dept Hepatol, Chandigarh, India
[3] Asian Inst Gastroenterol, Dept Hepatol, Hyderabad, India
[4] Apollo Multispecial Hosp, Dept Radiol & Imaging, Kolkata, India
关键词
Non-alcoholic fatty liver disease; Liver steatosis; Alcoholic fatty liver; GAMMA-GLUTAMYL-TRANSFERASE;
D O I
10.7570/jomes23063
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Steatotic liver disease (SLD) encompasses metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-associated liver disease (AALD) at extremes as well as an overlap group termed MASLD with increased alcohol intake (MetALD). The Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index (ANI) was proposed to differentiate ALD from nonalcoholic fatty liver disease (NAFLD). We analysed the performance of the ANI in differentiating within the SLD spectrum. Methods: In a cross-sectional study at a tertiary care center, 202 adults (>18 years) who were prospectively diagnosed with SLD defined by magnetic resonance imaging-proton density fat fraction > 6.4% were enrolled. Alcohol consumption (AC) was recorded according to thresholds for significant AC: 140-350 g/week (or 20- 50 g/day) for females and 210-420 g/week (or 30-60 g/day) for males. The ANI was calculated, and area under the receiver operating characteristic curve (AUROC) was generated. Results: Of 202 patients (47 years [interquartile range, IQR, 38 to 55], 23.75% females, 77% obese, 42.1% with diabetes, 38.1% hypertensive, 28.7% statin use), 40.5% were ever-alcohol consumers; 120 (59%), 50 (24.7%), and 32 (15.8%) were MASLD (ANI, -3.7 [IQR, -7 to -1.6]; MetALD, - 1.45 [IQR, -2.4 to 0.28]; and AALD, 0.71 [IQR, -1.3 to 4.8], respectively; P< 0.05 for all). The AUROC of the ANI for MASLD and AALD was 0.79 (IQR, 0.72 to 0.84; cut-off < -3.5) and 0.80 (IQR, 0.74 to 0.86; cut-off > -1.49), respectively. The ANI outperformed aspartate transaminase/alanine transaminase (AST/ALT) ratio (AUROC=0.75 [IQR, 0.69 to 0.81]) and gamma glutamyl transpeptidase (GGT) (AUROC=0.74 [IQR, 0.67 to 0.80]). Addition of GGT did not improve model performance (AUCdiff=0.004; P= 0.33). Conclusion: AC is common in MASLD. The ANI distinguishes MASLD and AALD, with individual cut-offs within the intermediate zone indicating MetALD. ANI also outperforms AST/ALT ratio or GGT.
引用
收藏
页码:222 / 228
页数:7
相关论文
共 50 条
  • [31] Vascular Disease in Patients with Nonalcoholic Fatty Liver Disease
    Potze, Wilma
    Siddiqui, M. Shadab
    Sanyal, Arun J.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2015, 41 (05): : 488 - 493
  • [32] Epidemiology of alcoholic and nonalcoholic fatty liver disease in China
    Fan, Jian-Gao
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 11 - 17
  • [33] Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Tilg, Herbert
    Moschen, Alexander R.
    Szabo, Gyongyi
    HEPATOLOGY, 2016, 64 (03) : 955 - 965
  • [34] Prognosis for the patients with alcoholic and nonalcoholic liver disease
    Colic-Cvrlje, V
    Naumovski-Mihalic, S
    Prskalo, M
    Colic, A
    Cvjeticanin, B
    Sabaric, B
    COLLEGIUM ANTROPOLOGICUM, 2000, 24 (01) : 249 - 252
  • [35] Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey
    Tokushige, Katsutoshi
    Hashimoto, Etsuko
    Horie, Yoshinori
    Taniai, Makiko
    Higuchi, Susumu
    JOURNAL OF GASTROENTEROLOGY, 2011, 46 (10) : 1230 - 1237
  • [36] HEPATOCELLULAR CARCINOMA IN JAPANESE PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE, ALCOHOLIC LIVER DISEASE AND CHRONIC LIVER DISEASE OF UNKNOWN ETIOLOGY: REPORT OF THE NATIONWIDE SURVEY
    Taniai, M.
    Hashimoto, E.
    Tokushige, K.
    Kodama, K.
    Kogiso, T.
    Torii, N.
    Shiratori, K.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S402 - S402
  • [37] Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey
    Katsutoshi Tokushige
    Etsuko Hashimoto
    Yoshinori Horie
    Makiko Taniai
    Susumu Higuchi
    Journal of Gastroenterology, 2011, 46 : 1230 - 1237
  • [38] Visceral adiposity index is not a predictor of liver histology in patients with nonalcoholic fatty liver disease
    Vongsuvanh, R.
    George, J.
    Van der Poorten, D.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 45 - 45
  • [39] VISCERAL ADIPOSITY INDEX IS NOT A PREDICTOR OF LIVER HISTOLOGY IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
    Vongsuvanh, Roslyn
    George, Jacob
    van der Poorten, David
    HEPATOLOGY, 2011, 54 : 1119A - 1119A
  • [40] Nonalcoholic Fatty Liver Disease and Liver Transplantation
    Tuan Pham
    Dick, Travis B.
    Charlton, Michael R.
    CLINICS IN LIVER DISEASE, 2016, 20 (02) : 403 - +